Senior insider sale
VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$202.3K
400.00 shares
What this filing means
BHATIA SANGEETA N. plans to sell 400.00 shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $202.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/2/2025ACC: 0001959173-25-002805
Director
Since Oct 2018
400.00
Shares to sell
$202.3K
Approx. market value
400.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/1/2025
400.00Total acquired400.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2025 | Restricted Stock Vesting Compensation | 400.00 | — |
| Total | 400.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
400.00
Market value
$202.3K
5/2/2025
Total
Units
400.00
Value
$202.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/2/2025 | 400.00 | $202.3K | NASDAQ | Planned |
| Total | 400.00 | $202.3K | ||